These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3550164)

  • 1. Why a little aspirin is better than a lot.
    Merz B
    JAMA; 1987 Apr; 257(16):2135. PubMed ID: 3550164
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of 50 mg enteric-coated aspirin (Astrix) on thromboxane and prostacyclin synthesis.
    James MJ; Walsh JA; Foreman RK
    Aust N Z J Surg; 1987 Oct; 57(10):763-6. PubMed ID: 3322248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of low-dose aspirin on platelet aggregation and the biosynthesis of PGI2 and TXA2 in patients with coronary heart disease].
    Gao SW; Chen ZJ; Tao SQ
    Zhonghua Nei Ke Za Zhi; 1987 Apr; 26(4):209-12, 255. PubMed ID: 3308356
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of prostacyclin and platelet thromboxane A2 after low-dose aspirin.
    Preston FE; Whipps S; Jackson CA; French AJ; Wyld PJ; Stoddard CJ
    N Engl J Med; 1981 Jan; 304(2):76-9. PubMed ID: 7003384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress review: the relationship between dose of aspirin, side-effects and antithrombotic effectiveness.
    Hirsh J
    Stroke; 1985; 16(1):1-4. PubMed ID: 3880945
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacological correction of disorders of the prostacyclin- thromboxane balance in ischemic heart disease: problems and prospects].
    Markov KhM
    Kardiologiia; 1990 Apr; 30(4):111-8. PubMed ID: 2118578
    [No Abstract]   [Full Text] [Related]  

  • 7. Absence of differential inhibition of thromboxane A2 and prostacyclin by low and high dose aspirin in coronary artery disease.
    Klein RC; Beckman J; Peake G
    Can J Cardiol; 1987 Sep; 3(6):288-92. PubMed ID: 3322532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thromboxane A2 and prostacyclin generation in the microvasculature of patients with atherosclerosis--effect of low-dose aspirin.
    Kyrle PA; Minar E; Brenner B; Eichler HG; Heistinger M; Marosi L; Lechner K
    Thromb Haemost; 1989 Jun; 61(3):374-7. PubMed ID: 2508252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of thromboxane and prostacyclin biosynthesis in humans.
    Gréen K; Vesterqvist O
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():607-10. PubMed ID: 1825386
    [No Abstract]   [Full Text] [Related]  

  • 10. Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin.
    Clarke RJ; Mayo G; Price P; FitzGerald GA
    N Engl J Med; 1991 Oct; 325(16):1137-41. PubMed ID: 1891022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose-aspirin: treatment of the imbalance of increased thromboxane and decreased prostacyclin in preeclampsia.
    Saleh AA; Bottoms SF; Mammen EF
    Am J Perinatol; 1992 Jul; 9(4):311-3. PubMed ID: 1627229
    [No Abstract]   [Full Text] [Related]  

  • 12. Aspirin and other platelet active drugs. Relationship among dose, effectiveness, and side effects.
    Hirsh J; Salzman EW; Harker L; Fuster V; Dalen JE; Cairns JA; Collins R
    Chest; 1989 Feb; 95(2 Suppl):12S-18S. PubMed ID: 2644095
    [No Abstract]   [Full Text] [Related]  

  • 13. The aspirin dilemma revisited.
    N Engl J Med; 1984 May; 310(20):1326-7. PubMed ID: 6371528
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension.
    Benigni A; Gregorini G; Frusca T; Chiabrando C; Ballerini S; Valcamonico A; Orisio S; Piccinelli A; Pinciroli V; Fanelli R
    N Engl J Med; 1989 Aug; 321(6):357-62. PubMed ID: 2664523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maximal blockade of TxA2 without compromised PGI2 formation; a superior profile of the TxA2 receptor blocking drug GR32191 over aspirin.
    Lumley P; Keery RJ; Wharton KA; White BP; Watts IS
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():603-6. PubMed ID: 1825385
    [No Abstract]   [Full Text] [Related]  

  • 16. [Aspirin--yes, but 30 mg??].
    Frölich JC
    Z Kardiol; 1995 May; 84(5):344-7. PubMed ID: 7625095
    [No Abstract]   [Full Text] [Related]  

  • 17. In Vivo Platelet Activation and Aspirin Responsiveness in Type 1 Diabetes.
    Zaccardi F; Rizzi A; Petrucci G; Ciaffardini F; Tanese L; Pagliaccia F; Cavalca V; Ciminello A; Habib A; Squellerio I; Rizzo P; Tremoli E; Rocca B; Pitocco D; Patrono C
    Diabetes; 2016 Feb; 65(2):503-9. PubMed ID: 26470782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandins and aspirin-sensitive asthma.
    Szczeklik AJ; Gryglewski RJ
    Am Rev Respir Dis; 1978 Oct; 118(4):799-800. PubMed ID: 360898
    [No Abstract]   [Full Text] [Related]  

  • 19. Differential inhibition by aspirin of vascular and platelet prostaglandin synthesis in atherosclerotic patients.
    Weksler BB; Pett SB; Alonso D; Richter RC; Stelzer P; Subramanian V; Tack-Goldman K; Gay WA
    N Engl J Med; 1983 Apr; 308(14):800-5. PubMed ID: 6339916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disordered eicosanoid formation in pregnancy-induced hypertension.
    Meagher EA; FitzGerald GA
    Circulation; 1993 Sep; 88(3):1324-33. PubMed ID: 8353893
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.